WO2015081145A1 - Beverage cartridge containing pharmaceutical actives - Google Patents

Beverage cartridge containing pharmaceutical actives Download PDF

Info

Publication number
WO2015081145A1
WO2015081145A1 PCT/US2014/067518 US2014067518W WO2015081145A1 WO 2015081145 A1 WO2015081145 A1 WO 2015081145A1 US 2014067518 W US2014067518 W US 2014067518W WO 2015081145 A1 WO2015081145 A1 WO 2015081145A1
Authority
WO
WIPO (PCT)
Prior art keywords
child
cartridge
resistant
lidding
another example
Prior art date
Application number
PCT/US2014/067518
Other languages
English (en)
French (fr)
Inventor
Kurt Franklin Trombley
Original Assignee
The Procter & Gamble Company
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by The Procter & Gamble Company filed Critical The Procter & Gamble Company
Priority to CN201480064906.8A priority Critical patent/CN105848625B/zh
Priority to CA2929863A priority patent/CA2929863A1/en
Priority to EP14809262.0A priority patent/EP3073981B1/en
Priority to AU2014354787A priority patent/AU2014354787B2/en
Priority to MX2016006449A priority patent/MX2016006449A/es
Priority to RU2016118811A priority patent/RU2669392C1/ru
Publication of WO2015081145A1 publication Critical patent/WO2015081145A1/en
Priority to AU2017245390A priority patent/AU2017245390B2/en

Links

Classifications

    • BPERFORMING OPERATIONS; TRANSPORTING
    • B65CONVEYING; PACKING; STORING; HANDLING THIN OR FILAMENTARY MATERIAL
    • B65DCONTAINERS FOR STORAGE OR TRANSPORT OF ARTICLES OR MATERIALS, e.g. BAGS, BARRELS, BOTTLES, BOXES, CANS, CARTONS, CRATES, DRUMS, JARS, TANKS, HOPPERS, FORWARDING CONTAINERS; ACCESSORIES, CLOSURES, OR FITTINGS THEREFOR; PACKAGING ELEMENTS; PACKAGES
    • B65D85/00Containers, packaging elements or packages, specially adapted for particular articles or materials
    • B65D85/70Containers, packaging elements or packages, specially adapted for particular articles or materials for materials not otherwise provided for
    • B65D85/804Disposable containers or packages with contents which are mixed, infused or dissolved in situ, i.e. without having been previously removed from the package
    • B65D85/8043Packages adapted to allow liquid to pass through the contents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61JCONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
    • A61J3/00Devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms
    • A61J3/002Compounding apparatus specially for enteral or parenteral nutritive solutions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61JCONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
    • A61J1/00Containers specially adapted for medical or pharmaceutical purposes
    • A61J1/14Details; Accessories therefor
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61JCONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
    • A61J1/00Containers specially adapted for medical or pharmaceutical purposes
    • A61J1/14Details; Accessories therefor
    • A61J1/1406Septums, pierceable membranes
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61JCONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
    • A61J1/00Containers specially adapted for medical or pharmaceutical purposes
    • A61J1/14Details; Accessories therefor
    • A61J1/20Arrangements for transferring or mixing fluids, e.g. from vial to syringe
    • A61J1/2093Containers having several compartments for products to be mixed
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61JCONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
    • A61J3/00Devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61JCONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
    • A61J1/00Containers specially adapted for medical or pharmaceutical purposes
    • A61J1/14Details; Accessories therefor
    • A61J1/20Arrangements for transferring or mixing fluids, e.g. from vial to syringe
    • A61J1/2003Accessories used in combination with means for transfer or mixing of fluids, e.g. for activating fluid flow, separating fluids, filtering fluid or venting
    • A61J1/202Separating means
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61JCONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
    • A61J1/00Containers specially adapted for medical or pharmaceutical purposes
    • A61J1/14Details; Accessories therefor
    • A61J1/20Arrangements for transferring or mixing fluids, e.g. from vial to syringe
    • A61J1/2003Accessories used in combination with means for transfer or mixing of fluids, e.g. for activating fluid flow, separating fluids, filtering fluid or venting
    • A61J1/202Separating means
    • A61J1/2027Separating means having frangible parts

Definitions

  • the present invention is related to a beverage cartridge and more particularly, a cartridge that is adapted to make beverages containing pharmaceutical actives.
  • a child-resistant cartridge adapted to fit an automatic brewing machine comprising: (a) a base wherein the base contains a pharmaceutical active; and (b) a lidding wherein the lidding comprises a multilayer laminate comprising an outer layer and an inner layer; wherein the cartridge is made of tear resistant materials sufficient to prevent 70% of children from accessing the contents of five or more cartridges during a Child-Resistant Screening Test.
  • a child-resistant multi-layer laminate lidding adapted for a cartridge comprising: (a) an outer layer; and (b) an inner layer; wherein the lidding is made of tear resistant materials sufficient to prevent 70% of children from accessing the contents of five or more cartridges by puncturing the lidding during a Child-Resistant Screening Test and wherein the lidding is penetrable by a needle or other penetrator of an automatic brewing machine.
  • a child-resistant cartridge adapted to fit an automatic brewing machine comprising: (a) a base wherein the base contains a pharmaceutical active; and (b) a lidding; wherein the cartridge is made of tear resistant materials sufficient to prevent 70% of children from accessing the contents of five or more cartridges during a Child-Resistant Screening Test.
  • FIG. 1 is a three-dimensional exploded view of a beverage cartridge
  • FIG. 2 is a side sectional view of a beverage cartridge of FIG. 1;
  • FIG. 3 is a side sectional view of a lidding for a beverage cartridge
  • FIG. 4A is a lidding for a beverage cartridge
  • FIG. 4B is a lidding for a beverage cartridge
  • FIG. 5 is a side sectional view of a beverage cartridge with two compartments
  • FIG. 6 is an example of a side sectional view of a beverage cartridge with two chambers.
  • FIG. 7 is an example three-dimensional exploded view of a beverage cartridge with a filter.
  • the current cartridges are not adapted to be used with pharmaceutical actives for two reasons.
  • the current cartridge does not provide a sufficient barrier to environmental conditions to prevent degradation.
  • the current cartridges are not child-resistant. It has been observed that children are able to open the current cartridges with their teeth and then using their fingers to peel off the lidding to access the contents or by applying pressure to the lidding with their thumb to puncture the lidding. Furthermore, once a child figured out how to open one cartridge, he was able to quickly open additional cartridges.
  • the cartridges of the present invention can provide a sufficient barrier from environmental conditions including humidity and gases, including oxygen, and can be child- resistant.
  • the structure and/or material(s) of the base and/or the lidding can provide long term stability for the pharmaceutical actives and/or child-resistance.
  • the cartridge can have a base and a lidding structure.
  • the base can be a multi-layer laminate, which can include polychlorotrifluoroethylene (PCTFE), an adhesive, and polyethylene terephthalate with a glycol modifier (PETG).
  • the lidding can be a multi-layer laminate structure that can comprise aluminum foil, adhesive, and a plastic.
  • the base and/or the lidding can be tear resistant. Furthermore, while being child-resistant, the bottom of the base and/or the lidding can still be penetrable by a needle or penetrator of the automatic brewing machine.
  • the cartridge can be adapted for use in an automatic machine such as a single serving automatic brewing machine.
  • Some of these machines can have a penetrator or needle that can penetrate the lidding and then provide a flow of water, frequently hot water, through the hole in the lidding, while a second penetrator or needle pushes through the bottom of the base to receive the outflow of the beverage and dispense it into a cup or container.
  • the base and the lidding layer are child resistant, in some examples, they can be penetrated by a penetrator or needle of a brewing machine.
  • the child-resistant and/or barrier features do not interfere with normal operation of the automatic brewing machine.
  • active or “pharmaceutical active” includes all compounds and compositions that can be used to treat and/or prevent illness and/or provide overall health and wellness benefits in mammals, particularly humans.
  • particularly useful actives include over-the-counter (OTC) actives, behind the counter actives, and prescription actives, vitamins, minerals, plant-derived materials, energy boosting materials, probiotics, fiber, prebiotics, and combinations thereof.
  • OTC over-the-counter
  • child-resistant means a cartridge or other packaging that is designed or constructed to be significantly difficult for young children to open or obtain a toxic or harmful amount of the substance contained therein within a reasonable time and not difficult for normal adults to use properly, but does not mean packaging which all such children cannot open or obtain a toxic or harmful amount within a reasonable time.
  • solvent refers to passing into solution.
  • disintegrate refers to breaking up into small parts.
  • primary packaging refers a packaging component that is or may be in direct contact with the dosage form.
  • releasably joined refers to configurations in which a first element is secured to a second element, such that the first element and the second element can be separated with no or minimal damage to the first and second elements.
  • tear resistant means capable of experiencing a reasonable level of stress and/or deformation without experiencing a significant loss of integrity. Stress and/or deformation can be applied by a number of movements including, but not limited to, biting, pulling, pealing, poking, pushing and/or jabbing at the cartridge. In one example, any of these movements can be performed by a child, and tear resistant refers to a material that is capable of experiencing a reasonable level of stress and/or deformation without experiencing a significant loss of integrity when undergoing forces that can be applied by a child. In one example, the child is six years or younger, in another example five years or younger, in another example four years or younger, in another example three or younger, in another example two or younger, and in another example 18 months or younger. In one example, even though the cartridge is tear resistant, it can still be punctured with the needle or penetrator of an automatic brewing machine.
  • the term “treat” or “treating” includes preventing, alleviating, ameliorating, inhibiting, or mitigating one or more health conditions in a mammal, in particular a human and in one example an adult human.
  • health conditions can include respiratory conditions.
  • FIG. 1 shows an exploded view of cartridge 1 and FIG. 2 shows a side sectional view of cartridge 1.
  • Cartridge 1 includes base 10 and lidding 20.
  • Base 10 includes opening 11 and outwardly facing rim 13.
  • Base 10 can have the shape of a cup, cylinder, bowl, or an inverted truncated cone.
  • Base 10 can include component 12, which can include an active and/or an excipient. In one example, the component can be a powder.
  • Bottom 15 of base 10 can be penetrable by a penetrator or needle during use.
  • inner surface 26 of lidding 20 can be permanently joined to rim 13 of base 10 at seal 25.
  • the lidding can be joined to the base by any suitable method.
  • the lidding has a coating that is heat activated, causing it to attach to the rim of the base when exposed to heat.
  • the lidding can be attached using ultrasonic frequency and in another example the lidding can be attached using induction heating.
  • the lidding can be attached with a contact adhesive.
  • Lidding 20 can be a child-resistant laminate with outer layer 21 and inner layer 22.
  • Outer layer 21 can provide the child-resistance and can be tear resistant while still be penetrable by a needle or other penetrator of an automatic brewing machine.
  • outer layer 21 can contain reinforced strands 24, which can provide additional child resistance. Reinforced strands 24 can form a mesh across lidding 20 and in one example, the mesh can be open at the location where the lidding is intended to be punctured by a needle or penetrator.
  • the reinforced strands can be embedded in the child-resistant laminate.
  • the reinforced strands are underneath the outer layer.
  • the reinforced strands can be underneath the inner layer.
  • the reinforced strands can be between the outer layer and the inner layer. In another example, the reinforced strands can be embedded in the outer layer and/or the inner layer.
  • the reinforced strands can be made of any suitable material including nylon, polypropylene, fiberglass, and combinations thereof.
  • Inner layer 22 can reduce the amount of gasses, including oxygen, from entering cartridge
  • Inner layer 22 can be made out of any suitable material and in one example, inner layer 22 can be made out of aluminum foil. Inner layer 22 can be opaque which can provide additional child- resistance. In another example, inner layer 22 can also include ink. In one example, outer layer 21 and inner layer 22 are permanently joined by an adhesive.
  • the lidding can be both child-resistant and provide an adequate barrier from gasses and humidity, while still being penetrable by a needle or other penetrator of an automatic brewing machine.
  • the lidding is a laminate.
  • the laminate can have any number of layers.
  • the laminate has at least two layers, in another example at least three layers, in another example at least four layers, and in another example at least five layers.
  • the lidding can be only one layer.
  • one or more layers of the lidding can be opaque and in another example one or more layers of the lidding can be transparent.
  • FIG. 3 is an example of a side sectional view of lidding 30 for a beverage cartridge.
  • Lidding 30 can comprise outer layer 32, second layer 33, third layer 34, and inner layer 35.
  • outer layer 32 can comprise polyethylene terephthalate (PET)
  • second layer 33 can comprise orientated polyamide (OPA)
  • third layer 34 can comprise aluminum
  • inner layer 35 can comprise polyethylene vinyl acetate (PE-EVA).
  • inner layer 35 can comprise linear low-density polyethylene (LLDPE).
  • each layer is attached to an adjacent layer with an adhesive.
  • ink is between the outer layer and the second layer.
  • ink is printed on the outer layer.
  • a heat seal coating partially or entirely covers the inner layer.
  • FIGS. 4A and 4B are examples of liddings with weakened areas.
  • the weakened area can be in the region that is intended to be punctured by a needle or other penetrator of an automatic brewing machine. This weakened area can allow the lidding to be child resistant while still allowing the lid to be penetrated by a needle or penetrator.
  • the weakened area can extend partially or completely through one or more layers of the laminate lidding. In one example, the weakened area is on the outer layer of the lidding. In another example, the weakened area is not on the outer layer of the lidding because a child could see the weakened area and gain access or pick and peel at an edge of the weakened area. In one example, the weakened area does not penetrate the inner layer.
  • the weakened area only penetrates or partially penetrates the outer layer.
  • the weakened can be small enough so it is difficult for a child to use it to access the cartridge contents.
  • the weakened area is from about 1 mm to about 12 mm at its widest point, in another example from about 2 mm to about 10 mm, and in another example from about 3 mm to about 8 mm.
  • FIG. 4A is an example of lidding 40 with a weakened area, hole 42.
  • the hole can be any suitable shape. Non-limiting examples of shapes can include a circle, square, diamond, rectangle, triangle, star, cross, oval, and combinations thereof.
  • FIG. 4B is an example of lidding 45 with a weakened area, scored portion 47.
  • Scored portion 47 can be in any of the shapes listed above, as well as an "x”, cross-hatching, multiple dots, and combinations thereof.
  • FIG. 5 is an example of a side sectional view of beverage cartridge 5 with more than one compartment.
  • the actives and/or excipients are incompatible and separating them prolongs the stability of the components.
  • the components are in different states, for example one component is a solid and the other is a liquid.
  • one compartment contains a component with an active and another compartment contains a component with a flavor, which could allow for more robust flavor delivery, particularly if the flavor was a liquid.
  • beverage cartridge 5 has first compartment 51 containing first component 53 and second compartment 52 containing second component 54.
  • First compartment 51 and second compartment 52 are separated by divider 55.
  • the divider can be any suitable material.
  • the divider partially or completely dissolves or partially or completely disintegrates, when exposed to hot or cold water.
  • the divider can be a mesh or woven material that separates the components when they are solid but when the components dissolve in water, the solution can travel through the mesh or woven material.
  • the divider can be punctured with the needle or penetrator from the automatic brewing machine. When the divider is punctured, water and the second component can flow from the second compartment to the first compartment.
  • the beverage cartridge can have multiple compartments.
  • the beverage cartridge can have at least two compartments, in another example at least three compartments, and in another example at least four compartments.
  • the compartments can extend in any direction including horizontally across the cartridge, vertically from the bottom of the base to the lidding, diagonally, or combinations thereof.
  • FIG. 6 is an example of side sectional view of beverage cartridge 6 with multiple chambers.
  • Cartridge 6 has first chamber 61 containing first component 63 and second chamber 62 containing second component 64.
  • the chambers not only can keep the components separate until just before use but they can also allow the user to select which actives she wants in her beverage.
  • the automatic brewing machine can have an upper needle 66, which punctures lidding 65, approximately in the center, and does not puncture first chamber 61 or second chamber 62. Simultaneously, lower needle 67 punctures the bottom 68 of base 69 and chamber 63. Lower needle 67 does not puncture the middle of base 67, instead it punctures off center.
  • the chambers can be made of a frangible material and/or can be pre- scored so when the lower needle punctures the chamber it cracks or breaks completely in two or more parts.
  • Non-limiting examples of frangible materials can include starch based films, water soluble modified cellulose films such as hydroxyethyl cellylose, ethyl vinyl acetate films, and combinations thereof.
  • water soluble modified cellulose films such as hydroxyethyl cellylose, ethyl vinyl acetate films, and combinations thereof.
  • the first chamber may contain an active to treat aches and pains, such as acetaminophen or ibuprofen
  • the second chamber may contain an active to treat cough, such as dextromethorphan. If the consumer does not have a cough she can position the cartridge in the automatic beverage brewer such that only the chamber that has the actives for aches and pains is penetrated by the bottom needle. However, if the consumer wants both actives she can brew twice, puncturing both chambers.
  • the chamber can contain different flavors allowing the user to select a flavor of her beverage.
  • the upper needle can puncture both chambers.
  • the lower needle punctures only one chamber and liquid from the upper needle can flow into both chambers but the beverage will only be able to flow out of the chamber punctured by lower needle.
  • the consumer can make a beverage with the desired components.
  • the cartridge can have any suitable number of chambers.
  • the cartridge can have at least two chambers, in another example at least three chambers, and in another example at least four chambers.
  • the cartridge could have a single chamber that could allow the consumer to make a beverage with just the component outside the chamber or with both components.
  • the chambers can be used to separate incompatible components.
  • FIG. 7 is an example of a cartridge 7 with a base 70, lidding 71, and a filter 72.
  • Filter 72 contains component 73.
  • the filter can be used when brewing a drink, such as coffee or tea. The water will seep through the filter and extract the essence of the components and the solid particles will be retained in the filter.
  • the actives and/or other excipients can dissolve into the water as it passes through the filter.
  • the cartridge with a filter can be used to brew coffee or tea containing actives.
  • the cartridge does not contain a filter.
  • the ingredients are packaged in a separate container and added by the consumer, or person preparing the beverage for the consumer, before or after their beverage is brewed by the automatic brewing machine.
  • the ingredient can be a flavor and in another example the ingredient can contain one or more actives.
  • the separate container can be a sachet.
  • the separate container can contain a liquid.
  • the separate container can contain a solid, where the solid can be a powder, nonpareils, capsule, tablet, or combinations thereof.
  • the consumer uses the automatic brewing system to puncture the top of the cartridge but before brewing the beverage the consumer reopens the machine and adds the separately packaged ingredient to the cartridge through the hole made by the automatic brewing machine and then recloses the machine and brews their beverage.
  • the base can be made of any suitable material(s) that provide the desired barrier properties and child-resistance and can still be penetrated by the needle or penetrator of the automatic brewing machine.
  • Non-limiting examples of materials that can be incorporated into the laminate material of the base can include high-density polyethylene (HDPE), cyclic olefin copolymers (COC), biaxally orientated polyamide (OP A), polypropylene (PP), polyester (PET), amorphous polyethylene terephthalate (APET), polyvinyl chloride (PVC), polyethylene (PE), aluminum foil, and combinations thereof.
  • the laminate can include a polyvinylidene chloride coating and in another example the laminate can include ethylvinyl alcohol (EVOH).
  • the base can be transparent and in another example the base can be opaque.
  • the base can be a laminate made from polychlorotrifluoroethene (PCTFE), an optional adhesive, and polyethylene terepthalate glycol (PETG).
  • PETG can be from about 25 ⁇ to about 1.5 mm thick, in another example from about 50 ⁇ to about 1 mm, in another example from about 100 ⁇ to about 500 ⁇ , and in another example from about 200 ⁇ to about 300 ⁇ .
  • the PCTFE can be from about 10 ⁇ to about 250 ⁇ , in another example from about 25 ⁇ to about 150 ⁇ , in another example from about 30 ⁇ to about 100 ⁇ , and in another example from about 40 ⁇ to about 75 ⁇ .
  • the base can be a laminate with an inner layer and an outer layer.
  • the inner layer can be EVOH, or another material that is difficult for a child to puncture or tear.
  • the inner layer and the outer layer of the base can be releasably joined.
  • the inner layer can separate from the outer layer. This separation can slow the child down, which can give a parent or caregiver more time to intervene and prevent the child from accessing cartridges. This separation may also make the child feel like they are making progress getting the package open, when in reality delaminating these two layers is not contributing to gaining access to the component, since the child cannot break through the inner and/or outer layer.
  • the maximum thickness of the base material can be greater than the maximum thickness of current pharmaceutical product barrier materials, such as cavities on a blister card, because the cartridge has dimensions larger than a typical pharmaceutical product enclosure.
  • base material with a greater starting thickness provides for sufficient thickness when the base of the cartridge is formed because the material is stretched by a greater degree towards the bottom of the cartridge base.
  • Current lidding can be removed by children with a combination of biting and scratching.
  • the lidding can be tear resistant.
  • the lidding is a multi-layer laminate.
  • Non- limiting examples of materials that can be incorporated into the laminate material of the lidding can include aluminum foil, PCTFE, EVOH, HDPE, OPA, COC, PP, PET, APET, PVC, PE, and combinations thereof.
  • the layers of the laminate can be affixed by an adhesive layer, which can comprise a polyolefin material like low density polyethylene (LDPE).
  • an adhesive layer which can comprise a polyolefin material like low density polyethylene (LDPE).
  • the laminate can have an outer layer, a second layer, and an inner layer.
  • the outer layer can be PET
  • the second layer can be foil
  • the inner layer can be LLDPE.
  • the outer layer or PET layer can be from about 5 ⁇ to about 40 ⁇ thick, in another example from about 10 ⁇ to about 35 ⁇ thick, in another example from about 15 ⁇ to about 30 ⁇ thick, and in another example from about 20 ⁇ to about 25 ⁇ thick. In one example the outer layer or PET layer can be greater than about 8 ⁇ , in another example greater than about 11 ⁇ , in another example greater than about 16 ⁇ , in another example greater than about 20 ⁇ , and in another example greater than about 22 ⁇ .
  • the second layer or foil layer can be from about 3 ⁇ to about 30 ⁇ , in another example from about 8 ⁇ to about 25 ⁇ thick, and in another example from about 15 ⁇ to about 22 ⁇ thick. In another example the second layer or foil layer can be greater than about 5 ⁇ thick, in another example greater than about 8 ⁇ thick, in another example greater than about 12 ⁇ thick, in another example greater than about 15 ⁇ thick, and in another example greater than about 17 ⁇ thick.
  • the inner layer or LLDPE layer can be from about 10 ⁇ to about 40 ⁇ thick, in another example from about 15 ⁇ to about 35 ⁇ thick, in another example from about 20 ⁇ to about 30 ⁇ thick, and in another example from about 22 ⁇ to about 27 ⁇ thick.
  • the inner layer or LLDPE layer can be greater than about 8 ⁇ thick, in another example greater than about 13 ⁇ thick, in another example greater than about 18 ⁇ thick, in another example greater than about 20 ⁇ thick, in another example greater than about 22 ⁇ thick, and in another example greater than 24 ⁇ thick.
  • the base, lidding, and/or cartridge can provide an effective barrier.
  • the base, lidding, and/or cartridge can have a final moisture vapor transmission rate of about 2 x 10 "5 to about 2 x 10 "3 g/cartridge/day, in another example from about 1 x 10 "4 to about 6 x 10 "4 g/cartridge/day, and in another example from about 2 x 10 "4 to about 3 x 10 "4 g/cartridge/day, as determined by the United States Pharmacopeial (USP) ⁇ 671> (August 1, 2013).
  • USP United States Pharmacopeial
  • the cartridge can provide long term stability to the pharmaceutical actives.
  • the pharmaceutical active in the cartridge have a shelf life of at least about 1 year, in another example at least about 18 months, in another example at least about 2 years, and in another example at least about 2.5 years.
  • shelf life refers to the time period during which a drug product is expected to remain within the approved shelf life specification, provided that it is stored under the conditions defined on the container label.
  • shelf life testing The conditions under which shelf life testing is conducted, the specific measurements and the minimum requirements for usable, fit for consumption or saleable can be set by governmental or regulatory bodies and can be published in guidance documents such as the United States Pharmacopeial (USP) or ICH Harmonised Tripartite Guideline Stability Testing of New Drug Substances and Products Q1A(R2), Step 4, of the version published February 6 th , 2003.
  • USP United States Pharmacopeial
  • ICH Harmonised Tripartite Guideline Stability Testing of New Drug Substances and Products Q1A(R2), Step 4 of the version published February 6 th , 2003.
  • the pharmaceutical active is at least about 90% of label for at least 1 year, in another example for at least about 1.5 years, in another example for at least about 2 years, and in another example for at least about 3 years. In another example the pharmaceutical active is at least about 95% of label for at least 1 year, alternatively at least about 1.5 years, alternatively at least about 2 years.
  • the cartridge may provide long term stability by maintaining the pharmaceutical active above about 80% or label for at least about 1 year, alternatively at least about 1.5 years, alternatively at least 2 years.
  • the cartridges can be in secondary packaging.
  • the secondary package can be a standard paperboard box that contains from about 1 to about 12 cartridges, and in another example from about 3 to about 6 cartridges.
  • the secondary package can be child-resistant.
  • the secondary package can contribute to the overall child- resistance of the cartridge.
  • each cartridge is individually packaged in a secondary package.
  • the secondary packaging can provide additional barrier properties to help prolong stability of the components.
  • the cartridge can be used with an automatic brewing machine and can be adapted to fit in an automatic brewing machine. In another example, the cartridge can be used without an automatic brewing machine. In one example, the cartridges are disposable which means that the cartridge can be disposed of or discarded after a limited number of uses. In one example, the cartridge can be used five or fewer times, in another example three or fewer times, in another example two or fewer times, and in another example the cartridge is used only one time. In another example, the cartridge can be reused and can be refilled with a component containing an active and/or an excipient.
  • the component can include both one or more actives and/or one or more excipients.
  • the component can be in any suitable form including, but not limited to, a powder, a liquid, a gel, or a tablet.
  • excipients can include flavors, sweeteners, disintegrants, fillers, colors, lubricants, glidants, sorbents, preservatives, sensates, and combinations thereof.
  • the component is a powder that dissolves as the water passes through the cartridge.
  • the component is a concentrated liquid that can be diluted when the water passes through the cartridge.
  • the component is only partially dissolved or extracted to make the beverage.
  • the cartridge can contain one or more actives.
  • the beverage containing actives can be consumed by adults and children 12 years and over.
  • the beverage containing actives can be intended to be consumed by children, often under the supervision of an adult.
  • the actives can treat a variety of symptoms including, but not limited to, symptoms from cold, flu, or allergies.
  • Non-limiting examples of actives can include decongestants, expectorants, antihistamines, antitussives, pain relievers, and combinations thereof.
  • the cartridge can provide multi-symptom relief of cold and/or flu symptoms and can be intended for use at night.
  • the cartridge can deliver about 650 mg acetaminophen, about 30 mg dextromethorphan HBr, about 10 mg of phenylephrine, about 30 to about 60 mg of pseudoephedrine, and/or about 12.5 mg doxylamine succinate during a single brew cycle.
  • how much active is delivered does not necessarily mean that the cartridge contains this amount of active.
  • the cartridge will likely contain more active than what is delivered to the user since in some examples, not all of the active will be transferred from the cartridge to the beverage.
  • the delivered amount of active can be within 10% of the monographed amount.
  • the cartridge can help relieve occasional sleeplessness and/or can help reduce the time to fall asleep if you have difficulty falling asleep.
  • the cartridge can provide about 50 mg diphenhydramine HC1 or about 25 mg of doxylamine succinate.
  • the cartridge can help the user treat allergy symptoms.
  • the cartridge can deliver about 25 mg to about 50 mg diphenhydramine HC1, about lOmg loratadine, about 650 mg to about 1000 mg acetaminophen, about 7.5 mg to about 12.5 mg doxylamine, and/or about 10 mg phenylephrine.
  • the cartridges can be sold in combination with other products, in particular products containing over-the-counter actives or vitamins and/or minerals.
  • the cartridge can contain actives intended for nighttime relief of cold and/or flu symptoms and the cartridge can be packaged or otherwise sold in combination with actives intended for daytime relief of cold and/or flu symptoms such as acetaminophen, dextromethorphan, and phenylephrine.
  • the cartridge can contain vitamins, for instance a tea containing vitamins, and it can be packaged or otherwise sold in combination with over-the-counter actives, for instance actives containing daytime and/or nighttime relief of cold and/or flu symptoms.
  • the over-the-counter actives can be any dosage form including, but not limited to, a liquid, solid dosage forms such as liquicaps or tablets, or a cartridge.
  • the automatic brewing machine can dispense an entire dose of active as determined by the monograph.
  • the active can quickly dissolve or can be extracted into water as it is being brewed.
  • the cartridge can contain more than the monographed dosage of the active in order to ensure that the correct dosage is in the consumer's cup.
  • the beverage can be any volume.
  • the beverage is from about 100 mL to about 500 mL, in another example from about 125 mL to about 250 mL, in another example from about 130 mL to about 250 mL, and in another example about 150 mL to about 200 mL.
  • the beverage is about 6 fluid ounces (177.41 mL) and in another example the beverage is about 8 fluid ounces (236.59 mL).
  • the automatic brewing machine can be rinsed with water or otherwise cleaned to remove residual actives and/or excipients.
  • a brewing cycle can be conducted by the consumer without a cartridge in the machine.
  • the automatic brewing machine can be cleaned with water.
  • the automatic brewing machine can be cleaned with a cleaning agent, for instance a cleaning agent comprising vinegar.
  • the cartridge can be child-resistant and can be given a rating that is referred to as the F value.
  • the F Value refers to the number of unit doses to which access is considered a test failure.
  • the number following the "F" refers to the number of unit doses that may produce serious personal injury or serious illness based on a 25-pound (11.4 kg) child.
  • the Child-Resistant Test is a standardized test and can be found in 16 C.F.R. ⁇ 1700 Poison Prevention Packaging.
  • about 80% or more of the children in the child resistance test cannot access the contents of 3 cartridges or fewer, in another example about 70% or more of the children cannot access the contents of 3 cartridges or fewer, in another example about 60% or more of the children cannot access the contents of 3 cartridges or fewer. In another example, about 80% or more of the children in the child resistance test cannot access the contents of 2 cartridges or fewer, in another example about 70% or more of the children cannot access the contents of 2 cartridges or fewer, in another example about 60% or more of the children cannot access the contents of 2 cartridges or fewer.
  • the child-resistant testing can be conducted according to the Code of Federal Regulations Title 16: Part 1700. Child-Resistant Screening Test
  • the Child- Resistant Screening Test can be conducted as follows:
  • test failure is defined as any child who gains access to the cartridge contents.
  • test was a failure if any child accessed the contents of three or more cartridges during the full 10 minutes of testing.
  • gained access to means that the actives have been removed or can be removed in whole or in part. In the case of a cartridge, the active can be removed if any amount of active can spill out of the cartridge if it is inverted. If a cartridge or package is breached and the contents are not removed but could be removed, this is still considered access.
  • the children are tested two at a time.
  • the two children are escorted to the test area and are seated so there is no physical barrier between the children and the tester.
  • the tester will talk to the children to make them at ease.
  • the children are not given the impression that they are in a race or a contest, they are not offered a reward, and they are not told that the test is a game or that it is fun.
  • To begin the test the tester shall hand the children identical cartridges and say "Please try and open this for me.” If the child refuses to participate after the test has started, the tester shall reassure the child and gently encourage the child to try. If the child continues to refuse, the tester shall ask the child to hold the cartridge in his/her lap until the other child is finished. This pair of children shall not be eliminated from the results unless the refusing child disrupts the participation of the other child.
  • the tester shall minimize conversations with the children as long as they continue to attempt to open their packages.
  • the tester shall not discourage the children verbally or with facial expressions. If a child gets frustrated or bored and stops trying to open his/her cartridge, the tester shall reassure the child and gently encourage the child to keep trying.
  • the children should be allowed freedom of movement to work on their cartridges as long as the tester can watch both children (e.g. they can stand up, get down on the floor, or bang or pry the package).
  • the children shall be allowed to talk to each other about opening the cartridges and shall be allowed to watch each other try to open packages. If the child opens his/her cartridge, the tester shall say, "Thank you,” and take the opened cartridge from the child and give the child another unopened cartridge.
  • the tester shall ask the children to put their cartridges down and then shall demonstrate how to open the cartridge. This demonstration is done by performing a demonstration of how to use the cartridge in the machine, a Keurig® K75 Platinum Edition brewer. The children shall not be allowed to continue to try to open their cartridges during the demonstration period. The tester shall say, "watch me use this package.” Once the tester gets the children's full attention, the tester shall hold the demo package approximately two feet from the children and open the package at a normal speed as if the tester were going to use the contents. There shall be no exaggerated opening movements. The tester shall not discuss or describe how to open the package. After opening the package, the tester shall show the children the package.
  • the tester begins the five minute period by saying, "now you try to open your packages.” If both children have not used their teeth to try to open their packages during the first 5 minutes, the tester shall say immediately before or soon after beginning the second 5-minute period, "You can use your teeth if you want to.” This is the only statement that the tester shall make about using teeth. The test shall continue for another five minutes or until both children have opened their packages, whichever comes first.
  • Example 1 shows the results from the Child-Resistant Screening Test.
  • the procedures for the Child-Resistant Screening Test were followed as described above.
  • the trial used Swiss Miss K-Cups® (purchased at Keurig.com, on October 25 th , 2013, lot number 6696 PL120, expiration date January 17, 2015).
  • Table 1 shows how many cartridges were opened and how long it took to open each one.
  • Table 2 describes how each of the cartridges that were opened was accessed.
  • the Child-Resistance Screening Test with the Swiss Miss K-Cups® had a 65% pass rate.
  • the container passed if the child opened two or fewer cartridges. This is not an acceptable level of child-resistance for beverage products that contain pharmaceutical products, especially products containing acetaminophen or diphenhydramine. Almost all of the children who accessed the contents, used their teeth to puncture the lidding. Thus, in order to make a child resistant cartridge it can be important to have a lidding that cannot be punctured or torn by biting.
  • One child opened the package by applying steady pressure with his thumb to puncture the foil lidding. Thus, the lidding can also be made child resistant if it is not susceptible to being opened by pressing.
  • Example 2 shows the results from the second Child-Resistant Screening Test utilizing laminate lidding structure believed to be superior to those tested in Example 1.
  • the procedures for the Child-Resistant Screening Test were followed as described above.
  • This example used the same base as Example 1 ; however the lidding had a different laminate structure.
  • the laminate had an outer layer, a second layer, and an inner layer.
  • the outer layer was 12 ⁇ PET, the second layer was 9 ⁇ foil, and the inner layer was 25 ⁇ LLDPE.
  • the outer layer was connected to the second layer with adhesive and the second layer was connected to the inner layer with adhesive.
  • the cartridges were filled with Ovaltine® (batch number #401158801G). Table 3, below, shows how many cartridges were opened and how long it took to open each one.
  • This Child-Resistance Screening Test with the laminate lidding of Example 2 had a 75% pass rate counting child #12 and a 80% pass rate if he was excluded.
  • the container passed if the child opened three or fewer cartridges. 75% is not an acceptable level of child-resistance (80% is the minimum level of acceptance) for beverage products that contain pharmaceutical products, especially products containing acetaminophen or diphenhydramine. Almost all of the children who accessed the contents, used their teeth or fingers to puncture the lidding. Thus, in order to make a child resistant cartridge it can be important to have a lidding that cannot be punctured or torn by biting.
  • Example 3 shows the results from the third Child-Resistant Screening Test utilizing new packaging component materials believed to be superior to those tested in Example 1 and Example 2.
  • the procedures for the Child-Resistant Screening Test were followed as described above.
  • the trial used the same base as Example 1; however the lidding had a different laminate structure.
  • the laminate had an outer layer, a second layer, and an inner layer.
  • the outer layer was 23 ⁇ PET, the second layer was 18 ⁇ foil, and the inner layer was 25 ⁇ LLDPE.
  • the outer layer was connected to the second layer with adhesive and the second layer was connected to the inner layer with adhesive.
  • the cartridges were filled with Ovaltine® (batch number #401158801G). Table 5, below, shows how many cartridges were opened and how long it took to open each one.
  • This Child-Resistance Screening Test with the laminate lidding of Example 3 had a 90% pass rate.
  • the container passed if the child opened three or fewer cartridges.
  • 90% is an acceptable level of child-resistance (80% is the minimum level of acceptance) for beverage products which contain pharmaceutical products, especially products containing acetaminophen or diphenhydramine .

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Mechanical Engineering (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Nutrition Science (AREA)
  • Packages (AREA)
  • Apparatus For Making Beverages (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Laminated Bodies (AREA)
PCT/US2014/067518 2013-11-27 2014-11-26 Beverage cartridge containing pharmaceutical actives WO2015081145A1 (en)

Priority Applications (7)

Application Number Priority Date Filing Date Title
CN201480064906.8A CN105848625B (zh) 2013-11-27 2014-11-26 包含药物活性物质的饮料筒
CA2929863A CA2929863A1 (en) 2013-11-27 2014-11-26 Beverage cartridge containing pharmaceutical actives
EP14809262.0A EP3073981B1 (en) 2013-11-27 2014-11-26 Beverage cartridge containing pharmaceutical actives
AU2014354787A AU2014354787B2 (en) 2013-11-27 2014-11-26 Beverage cartridge containing pharmaceutical actives
MX2016006449A MX2016006449A (es) 2013-11-27 2014-11-26 Cartucho de bebida que contiene ingredientes activos farmaceuticos.
RU2016118811A RU2669392C1 (ru) 2013-11-27 2014-11-26 Картридж для приготовления напитков, содержащий активные фармацевтические ингредиенты
AU2017245390A AU2017245390B2 (en) 2013-11-27 2017-10-12 Beverage cartridge containing pharmaceutical actives

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201361909556P 2013-11-27 2013-11-27
US61/909,556 2013-11-27

Publications (1)

Publication Number Publication Date
WO2015081145A1 true WO2015081145A1 (en) 2015-06-04

Family

ID=52014447

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2014/067518 WO2015081145A1 (en) 2013-11-27 2014-11-26 Beverage cartridge containing pharmaceutical actives

Country Status (7)

Country Link
EP (1) EP3073981B1 (ru)
CN (1) CN105848625B (ru)
AU (2) AU2014354787B2 (ru)
CA (1) CA2929863A1 (ru)
MX (1) MX2016006449A (ru)
RU (1) RU2669392C1 (ru)
WO (1) WO2015081145A1 (ru)

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102015115250A1 (de) * 2015-09-10 2017-03-16 Pester Pac Automation Gmbh Verwendung einer Verpackung
WO2017172605A1 (en) * 2016-03-30 2017-10-05 Eco 2, Llc Descaling device for a beverage machine and method of descaling a beverage machine
IT201600111266A1 (it) * 2016-11-04 2018-05-04 Safta Spa Capsula, metodo di fabbricazione, film multistrato
US20180265279A1 (en) * 2015-09-01 2018-09-20 LigaLife GmbH & Co. KG Capsule for Producing a Liquid Food Item, and a Method for Manufacturing a Capsule for the Production of a Liquid Food Item
WO2021059229A1 (en) * 2019-09-28 2021-04-01 Famatek Gmbh Insertable dosing/release system for supplemental ingredient for capsule comprising a main precursor and a supplemental ingredient and a method for production of said insertable dosing/release system and said capsule, and method for preparing a beverage

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10881582B2 (en) 2018-06-11 2021-01-05 Glaxosmithkline Consumer Healthcare Holdings (Us) Llc Individual dose pack
GR1010650B (el) * 2023-01-17 2024-03-12 Ιουλια Κλεωνος Τσετη Φαρμακευτικη συνθεση παρακεταμολης υπο υδατοδιαλυτη μορφη εντος ερμητικα κλειστου δοχειου για παρασκευη ζεστου ροφηματος

Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2154101A1 (en) * 2004-02-18 2010-02-17 MDS Global Holding LTD. Dispensing of a substance
US20110151075A1 (en) * 2009-12-18 2011-06-23 Green Mountain Coffee Roasters, Inc. Beverage formation apparatus and method using sonic energy
EP2551216A1 (de) * 2011-07-26 2013-01-30 Cavonic GmbH Verpackungsbehälter, Herstellungsverfahren sowie Herstellungsvorrichtung
US20130129870A1 (en) * 2010-02-01 2013-05-23 Green Mountain Coffee Roasters, Inc. Method and apparatus for cartridge-based carbonation of beverages
WO2013144838A1 (en) * 2012-03-26 2013-10-03 Sarong Societa' Per Azioni Capsule for beverage and method for manufacturing said capsule
WO2014127467A1 (en) * 2013-02-25 2014-08-28 2266170 Ontario Inc. Single serve capsule for improved extraction efficiency and flavor retention

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX2012008857A (es) * 2010-02-01 2012-12-05 Green Mountain Coffee Roasters Inc Metodo y aparato para carbonatacion de bebidas a basadas en cartuchos.

Patent Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2154101A1 (en) * 2004-02-18 2010-02-17 MDS Global Holding LTD. Dispensing of a substance
US20110151075A1 (en) * 2009-12-18 2011-06-23 Green Mountain Coffee Roasters, Inc. Beverage formation apparatus and method using sonic energy
US20130129870A1 (en) * 2010-02-01 2013-05-23 Green Mountain Coffee Roasters, Inc. Method and apparatus for cartridge-based carbonation of beverages
EP2551216A1 (de) * 2011-07-26 2013-01-30 Cavonic GmbH Verpackungsbehälter, Herstellungsverfahren sowie Herstellungsvorrichtung
WO2013144838A1 (en) * 2012-03-26 2013-10-03 Sarong Societa' Per Azioni Capsule for beverage and method for manufacturing said capsule
WO2014127467A1 (en) * 2013-02-25 2014-08-28 2266170 Ontario Inc. Single serve capsule for improved extraction efficiency and flavor retention

Cited By (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20180265279A1 (en) * 2015-09-01 2018-09-20 LigaLife GmbH & Co. KG Capsule for Producing a Liquid Food Item, and a Method for Manufacturing a Capsule for the Production of a Liquid Food Item
DE102015115250A1 (de) * 2015-09-10 2017-03-16 Pester Pac Automation Gmbh Verwendung einer Verpackung
WO2017172605A1 (en) * 2016-03-30 2017-10-05 Eco 2, Llc Descaling device for a beverage machine and method of descaling a beverage machine
US9999317B2 (en) 2016-03-30 2018-06-19 Thomas Jerige Descaling device for a beverage machine and method of descaling a beverage machine
IT201600111266A1 (it) * 2016-11-04 2018-05-04 Safta Spa Capsula, metodo di fabbricazione, film multistrato
WO2018083564A1 (en) * 2016-11-04 2018-05-11 Safta S.P.A. Capsule, manufacturing method, multilayer film
WO2021059229A1 (en) * 2019-09-28 2021-04-01 Famatek Gmbh Insertable dosing/release system for supplemental ingredient for capsule comprising a main precursor and a supplemental ingredient and a method for production of said insertable dosing/release system and said capsule, and method for preparing a beverage

Also Published As

Publication number Publication date
AU2017245390B2 (en) 2019-03-07
RU2669392C1 (ru) 2018-10-11
RU2016118811A (ru) 2017-12-28
MX2016006449A (es) 2016-07-19
EP3073981B1 (en) 2019-07-24
CN105848625A (zh) 2016-08-10
EP3073981A1 (en) 2016-10-05
AU2014354787A1 (en) 2016-05-19
CA2929863A1 (en) 2015-06-04
AU2014354787B2 (en) 2017-08-10
AU2017245390A1 (en) 2017-11-02
CN105848625B (zh) 2019-07-09

Similar Documents

Publication Publication Date Title
US9938075B2 (en) Beverage cartridge containing pharmaceutical actives
AU2017245390B2 (en) Beverage cartridge containing pharmaceutical actives
US10130557B2 (en) Child-resistant blister package
US5511665A (en) Child-resistant package
ES2525262T3 (es) Sistema de apertura de un blíster médico
JP2009233334A (ja) 医薬品用の引き裂き可能パッケージ及び方法
JP2005518909A (ja) 薬剤治療ブリスターカード
Lockhart et al. Packaging of pharmaceuticals and healthcare products
MX2010013298A (es) Empaque con compartimiento para distribuir dosis de un medicamento.
CN112334118A (zh) 单独剂量包装
EP2911948B1 (en) Sachet for a liquid medication
US20230053278A1 (en) Pharmacy assembly machine and packaging for customised polypills, and customised antipsychotic combinations for improved compliance
EA012345B1 (ru) Открываемая после сгибания упаковка для таблеток
CN101293582A (zh) 安全型泡罩包装
CA2759033A1 (en) Portable powder delivery system and method
RU2800895C2 (ru) Упаковка с индивидуальной дозой
CN201165381Y (zh) 安全型泡罩包装
WO2024118700A1 (en) An individual dose pod
JP3084962U (ja) インジケーター付ドリップ吸収シート

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 14809262

Country of ref document: EP

Kind code of ref document: A1

ENP Entry into the national phase

Ref document number: 2929863

Country of ref document: CA

REEP Request for entry into the european phase

Ref document number: 2014809262

Country of ref document: EP

WWE Wipo information: entry into national phase

Ref document number: 2014809262

Country of ref document: EP

WWE Wipo information: entry into national phase

Ref document number: MX/A/2016/006449

Country of ref document: MX

ENP Entry into the national phase

Ref document number: 2014354787

Country of ref document: AU

Date of ref document: 20141126

Kind code of ref document: A

NENP Non-entry into the national phase

Ref country code: DE

REG Reference to national code

Ref country code: BR

Ref legal event code: B01A

Ref document number: 112016011841

Country of ref document: BR

ENP Entry into the national phase

Ref document number: 2016118811

Country of ref document: RU

Kind code of ref document: A

ENP Entry into the national phase

Ref document number: 112016011841

Country of ref document: BR

Kind code of ref document: A2

Effective date: 20160524